These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3828945)

  • 21. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma.
    Chan KH; Gu YL; Ng F; Ng PS; Seto WH; Sham JS; Chua D; Wei W; Chen YL; Luk W; Zong YS; Ng MH
    Int J Cancer; 2003 Jul; 105(5):706-9. PubMed ID: 12740922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of nasopharyngeal carcinoma using IgA anti-EBNA1 + VCA-p18 serology assay.
    Romdhoni AC; Wiqoyah N; Kentjono WA
    Ear Nose Throat J; 2014 Mar; 93(3):112-5. PubMed ID: 24652560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visualization of a protein involved in seric immune complexes of patients with epithelial tumors having elevated levels of anti-'benzo[a]pyrene-like' IgA.
    Chagnaud JL; Bourême D; Faiderbe S; Geffard M
    Cancer Lett; 1991 Dec; 60(3):229-35. PubMed ID: 1756513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
    Süsal C; Maier H; Lorenz K; Opelz G
    Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on circulating immune complexes. II: Circulating immune complexes in primary IgA nephropathy and membranoproliferative glomerulonephritis.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):193-200. PubMed ID: 2739118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Neel HB; Pearson GR; Taylor WF
    Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):477-82. PubMed ID: 6093669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck.
    Veltri RW; Rodman SM; Maxim PE; Baseler MW; Sprinkle PM
    Cancer; 1986 Jun; 57(12):2295-308. PubMed ID: 3084060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay.
    Li Y; Wang K; Yin SK; Zheng HL; Min DL
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.
    González-Cabrero J; Egido J; Barat A; González E
    Immunology; 1990 Jul; 70(3):296-302. PubMed ID: 2379938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on circulating immune complexes. III: Kinetics of the immunoglobulin class of circulating immune complexes in systemic lupus erythematosus.
    Miura Y
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):201-9. PubMed ID: 2739119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
    Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
    Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sensitive and rapid enzyme-linked immunosorbent assay using monoclonal antibodies for simultaneous quantitation of free and IgA-complexed protein HC.
    Fernandez-Luna JL; Moneo I; Grubb A; Méndez E
    J Immunol Methods; 1985 Sep; 82(1):101-10. PubMed ID: 2411818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between progression of disease and immunoglobulin A-anti-Fab-/F(ab')2 autoantibodies in patients with head and neck cancer.
    Lorenz KJ; Süsal C; Opelz G; Maier H
    Otolaryngol Head Neck Surg; 1998 Jan; 118(1):130-6. PubMed ID: 9450843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits.
    Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT
    Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
    Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
    J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
    Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological follow-up study on the antibody levels to Epstein-Barr virus-determined nuclear antigen (EBNA) patients with nasopharyngeal carcinoma (NPC) after radiation therapy.
    Shimakage M; Ikegami N; Chatani M; Yoshino K; Sato T
    Biken J; 1987 Jun; 30(2):45-51. PubMed ID: 2830879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.